Walleye Capital LLC Viatris Inc Transaction History
Walleye Capital LLC
- $38.9 Billion
- Q4 2024
A detailed history of Walleye Capital LLC transactions in Viatris Inc stock. As of the latest transaction made, Walleye Capital LLC holds 99,900 shares of VTRS stock, worth $929,070. This represents 0.0% of its overall portfolio holdings.
Number of Shares
99,900
Previous 156,400
36.13%
Holding current value
$929,070
Previous $1.82 Million
31.52%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding VTRS
# of Institutions
1,141Shares Held
988MCall Options Held
2.34MPut Options Held
2.21M-
Vanguard Group Inc Valley Forge, PA142MShares$1.32 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY92.7MShares$862 Million0.02% of portfolio
-
State Street Corp Boston, MA63.7MShares$593 Million0.03% of portfolio
-
Chris Davis Davis Selected Advisers | Tucson, Az62.6MShares$582 Million4.62% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD58.7MShares$546 Million0.08% of portfolio
About Viatris Inc
- Ticker VTRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,212,669,952
- Market Cap $11.3B
- Description
- Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...